151 related articles for article (PubMed ID: 8700133)
21. The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy.
Buursma AR; Beerens AM; de Vries EF; van Waarde A; Rots MG; Hospers GA; Vaalburg W; Haisma HJ
J Nucl Med; 2005 Dec; 46(12):2068-75. PubMed ID: 16330572
[TBL] [Abstract][Full Text] [Related]
22. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
[TBL] [Abstract][Full Text] [Related]
23. Antipeptide antibodies confirm the topology of the human norepinephrine transporter.
Brüss M; Hammermann R; Brimijoin S; Bönisch H
J Biol Chem; 1995 Apr; 270(16):9197-201. PubMed ID: 7721836
[TBL] [Abstract][Full Text] [Related]
24. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
25. A Na(+)/Cl(-)-dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes).
Roubert C; Sagné C; Kapsimali M; Vernier P; Bourrat F; Giros B
Mol Pharmacol; 2001 Sep; 60(3):462-73. PubMed ID: 11502876
[TBL] [Abstract][Full Text] [Related]
26. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
Kocabas AM; Rudnick G; Kilic F
J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological properties of naturally occurring variants of the human norepinephrine transporter.
Runkel F; Brüss M; Nöthen MM; Stöber G; Propping P; Bönisch H
Pharmacogenetics; 2000 Jul; 10(5):397-405. PubMed ID: 10898109
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
Paczkowski FA; Bönisch H; Bryan-Lluka LJ
Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
[TBL] [Abstract][Full Text] [Related]
29. Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells.
Apparsundaram S; Sung U; Price RD; Blakely RD
J Pharmacol Exp Ther; 2001 Nov; 299(2):666-77. PubMed ID: 11602680
[TBL] [Abstract][Full Text] [Related]
30. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion.
Wang J; Shen F; Yan W; Wu M; Ratnam M
Biochemistry; 1997 Nov; 36(47):14583-92. PubMed ID: 9398177
[TBL] [Abstract][Full Text] [Related]
31. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Mash DC; Ouyang Q; Qin Y; Pablo J
J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.
Apparsundaram S; Moore KR; Malone MD; Hartzell HC; Blakely RD
J Neurosci; 1997 Apr; 17(8):2691-702. PubMed ID: 9092590
[TBL] [Abstract][Full Text] [Related]
33. External cysteine residues in the serotonin transporter.
Chen JG; Liu-Chen S; Rudnick G
Biochemistry; 1997 Feb; 36(6):1479-86. PubMed ID: 9063896
[TBL] [Abstract][Full Text] [Related]
34. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
Hahn MK; Robertson D; Blakely RD
J Neurosci; 2003 Jun; 23(11):4470-8. PubMed ID: 12805287
[TBL] [Abstract][Full Text] [Related]
35. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation.
Hahn MK; Mazei-Robison MS; Blakely RD
Mol Pharmacol; 2005 Aug; 68(2):457-66. PubMed ID: 15894713
[TBL] [Abstract][Full Text] [Related]
36. An E-box motif residing in the exon/intron 1 junction regulates both transcriptional activation and splicing of the human norepinephrine transporter gene.
Kim CH; Ardayfio P; Kim KS
J Biol Chem; 2001 Jul; 276(27):24797-805. PubMed ID: 11333263
[TBL] [Abstract][Full Text] [Related]
37. A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene.
Kim CH; Kim HS; Cubells JF; Kim KS
J Biol Chem; 1999 Mar; 274(10):6507-18. PubMed ID: 10037744
[TBL] [Abstract][Full Text] [Related]
38. Topological studies of hSVCT1, the human sodium-dependent vitamin C transporter and the influence of N-glycosylation on its intracellular targeting.
Velho AM; Jarvis SM
Exp Cell Res; 2009 Aug; 315(13):2312-21. PubMed ID: 19379732
[TBL] [Abstract][Full Text] [Related]
39. chi-Conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter.
Bryan-Lluka LJ; Bönisch H; Lewis RJ
J Biol Chem; 2003 Oct; 278(41):40324-9. PubMed ID: 12837768
[TBL] [Abstract][Full Text] [Related]
40. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
